Feed/Investors/Hikma Pharmaceuticals

Hikma Pharmaceuticals

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2024-03-06

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$119M

across 1 round

LATEST ROUND

Series E · $119M · 2024-03-06

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Rakuten Medical Rakuten Medical develops cancer therapies based on the Alluminox® platform, aimed at treating various cancers.	Series E Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$119M	2024-03-06	[ PART ]